These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23181752)

  • 21. The N-terminal unstructured domain of yeast ODC functions as a transplantable and replaceable ubiquitin-independent degron.
    Gödderz D; Schäfer E; Palanimurugan R; Dohmen RJ
    J Mol Biol; 2011 Apr; 407(3):354-67. PubMed ID: 21295581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining the geometry of the two-component proteasome degron.
    Inobe T; Fishbain S; Prakash S; Matouschek A
    Nat Chem Biol; 2011 Mar; 7(3):161-7. PubMed ID: 21278740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pupylation : A Signal for Proteasomal Degradation in Mycobacterium tuberculosis.
    Burns KE; Darwin KH
    Subcell Biochem; 2010; 54():149-57. PubMed ID: 21222280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Binding-induced folding of prokaryotic ubiquitin-like protein on the Mycobacterium proteasomal ATPase targets substrates for degradation.
    Wang T; Darwin KH; Li H
    Nat Struct Mol Biol; 2010 Nov; 17(11):1352-7. PubMed ID: 20953180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional dissection of the N-terminal degron of human thymidylate synthase.
    Melo SP; Yoshida A; Berger FG
    Biochem J; 2010 Nov; 432(1):217-26. PubMed ID: 20815815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flexible regions within I{kappa}B{alpha} create the ubiquitin-independent degradation signal.
    Mathes E; Wang L; Komives E; Ghosh G
    J Biol Chem; 2010 Oct; 285(43):32927-32936. PubMed ID: 20682784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new bioinformatics analysis tools framework at EMBL-EBI.
    Goujon M; McWilliam H; Li W; Valentin F; Squizzato S; Paern J; Lopez R
    Nucleic Acids Res; 2010 Jul; 38(Web Server issue):W695-9. PubMed ID: 20439314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing models of evolution for ordered and disordered proteins.
    Brown CJ; Johnson AK; Daughdrill GW
    Mol Biol Evol; 2010 Mar; 27(3):609-21. PubMed ID: 19923193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting proteins for degradation.
    Schrader EK; Harstad KG; Matouschek A
    Nat Chem Biol; 2009 Nov; 5(11):815-22. PubMed ID: 19841631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The intrinsically disordered N-terminal domain of thymidylate synthase targets the enzyme to the ubiquitin-independent proteasomal degradation pathway.
    Peña MM; Melo SP; Xing YY; White K; Barbour KW; Berger FG
    J Biol Chem; 2009 Nov; 284(46):31597-607. PubMed ID: 19797058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A distinct structural region of the prokaryotic ubiquitin-like protein (Pup) is recognized by the N-terminal domain of the proteasomal ATPase Mpa.
    Sutter M; Striebel F; Damberger FF; Allain FH; Weber-Ban E
    FEBS Lett; 2009 Oct; 583(19):3151-7. PubMed ID: 19761766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-folding IkappaBalpha alters control of NF-kappaB signaling.
    Truhlar SM; Mathes E; Cervantes CF; Ghosh G; Komives EA
    J Mol Biol; 2008 Jun; 380(1):67-82. PubMed ID: 18511071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural elements of the ubiquitin-independent proteasome degron of ornithine decarboxylase.
    Takeuchi J; Chen H; Hoyt MA; Coffino P
    Biochem J; 2008 Mar; 410(2):401-7. PubMed ID: 17979831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clustal W and Clustal X version 2.0.
    Larkin MA; Blackshields G; Brown NP; Chenna R; McGettigan PA; McWilliam H; Valentin F; Wallace IM; Wilm A; Lopez R; Thompson JD; Gibson TJ; Higgins DG
    Bioinformatics; 2007 Nov; 23(21):2947-8. PubMed ID: 17846036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitin-independent degradation of cell-cycle inhibitors by the REGgamma proteasome.
    Chen X; Barton LF; Chi Y; Clurman BE; Roberts JM
    Mol Cell; 2007 Jun; 26(6):843-52. PubMed ID: 17588519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ubiquitin- and ATP-independent proteolytic turnover of p21 by the REGgamma-proteasome pathway.
    Li X; Amazit L; Long W; Lonard DM; Monaco JJ; O'Malley BW
    Mol Cell; 2007 Jun; 26(6):831-42. PubMed ID: 17588518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteasome substrate degradation requires association plus extended peptide.
    Takeuchi J; Chen H; Coffino P
    EMBO J; 2007 Jan; 26(1):123-31. PubMed ID: 17170706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thymidylate synthase as a chemotherapeutic drug target: where are we after fifty years?
    Berger FG; Berger SH
    Cancer Biol Ther; 2006 Sep; 5(9):1238-41. PubMed ID: 17035726
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of N-terminal residues in the ubiquitin-independent degradation of human thymidylate synthase.
    Peña MM; Xing YY; Koli S; Berger FG
    Biochem J; 2006 Feb; 394(Pt 1):355-63. PubMed ID: 16259621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery of ubiquitinated substrates to protein-unfolding machines.
    Elsasser S; Finley D
    Nat Cell Biol; 2005 Aug; 7(8):742-9. PubMed ID: 16056265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.